Correlation Between Kalvista Pharmaceuticals and Syndax Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Kalvista Pharmaceuticals and Syndax Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kalvista Pharmaceuticals and Syndax Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kalvista Pharmaceuticals and Syndax Pharmaceuticals, you can compare the effects of market volatilities on Kalvista Pharmaceuticals and Syndax Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kalvista Pharmaceuticals with a short position of Syndax Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kalvista Pharmaceuticals and Syndax Pharmaceuticals.
Diversification Opportunities for Kalvista Pharmaceuticals and Syndax Pharmaceuticals
0.92 | Correlation Coefficient |
Almost no diversification
The 3 months correlation between Kalvista and Syndax is 0.92. Overlapping area represents the amount of risk that can be diversified away by holding Kalvista Pharmaceuticals and Syndax Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Syndax Pharmaceuticals and Kalvista Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kalvista Pharmaceuticals are associated (or correlated) with Syndax Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Syndax Pharmaceuticals has no effect on the direction of Kalvista Pharmaceuticals i.e., Kalvista Pharmaceuticals and Syndax Pharmaceuticals go up and down completely randomly.
Pair Corralation between Kalvista Pharmaceuticals and Syndax Pharmaceuticals
Given the investment horizon of 90 days Kalvista Pharmaceuticals is expected to generate 1.24 times more return on investment than Syndax Pharmaceuticals. However, Kalvista Pharmaceuticals is 1.24 times more volatile than Syndax Pharmaceuticals. It trades about 0.05 of its potential returns per unit of risk. Syndax Pharmaceuticals is currently generating about 0.04 per unit of risk. If you would invest 809.00 in Kalvista Pharmaceuticals on October 20, 2024 and sell it today you would earn a total of 21.00 from holding Kalvista Pharmaceuticals or generate 2.6% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Kalvista Pharmaceuticals vs. Syndax Pharmaceuticals
Performance |
| Timeline |
| Kalvista Pharmaceuticals |
| Syndax Pharmaceuticals |
Kalvista Pharmaceuticals and Syndax Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Kalvista Pharmaceuticals and Syndax Pharmaceuticals
The main advantage of trading using opposite Kalvista Pharmaceuticals and Syndax Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kalvista Pharmaceuticals position performs unexpectedly, Syndax Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Syndax Pharmaceuticals will offset losses from the drop in Syndax Pharmaceuticals' long position.| Kalvista Pharmaceuticals vs. Crinetics Pharmaceuticals | Kalvista Pharmaceuticals vs. Kura Oncology | Kalvista Pharmaceuticals vs. Viridian Therapeutics | Kalvista Pharmaceuticals vs. Replimune Group |
| Syndax Pharmaceuticals vs. Cogent Biosciences | Syndax Pharmaceuticals vs. Cullinan Oncology LLC | Syndax Pharmaceuticals vs. Kalvista Pharmaceuticals | Syndax Pharmaceuticals vs. Mersana Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
| CEOs Directory Screen CEOs from public companies around the world | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |